Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

1<sup>st</sup> EU-OPENSCREEN/SLAS data mining competition to predict compounds solubility.

SLAS discovery : advancing life sciences R & D·2025
Same author

Small molecule induced STING degradation facilitated by the HECT ligase HERC4.

Nature communications·2024
Same author

NIBR-LTSi is a selective LATS kinase inhibitor activating YAP signaling and expanding tissue stem cells in vitro and in vivo.

Cell stem cell·2024
Same author

Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control.

Cell reports·2023
Same author

Drug-induced eRF1 degradation promotes readthrough and reveals a new branch of ribosome quality control.

Cell reports·2023
Same author

Tyrosine kinase inhibitors can activate the NLRP3 inflammasome in myeloid cells through lysosomal damage and cell lysis.

Science signaling·2023
Same journal

From mitochondrial signal to discovery decision: a reserve-demand framework for translational risk assessment.

Expert opinion on drug discovery·2026
Same journal

Advances in 3D cell culture models for alzheimer's disease drug discovery.

Expert opinion on drug discovery·2026
Same journal

Are patient-derived models of amyotrophic lateral sclerosis a game changer for novel drug discovery?

Expert opinion on drug discovery·2026
Same journal

Unfolding prion misfolding and the challenge of identifying effective therapeutics: is there hope on the horizon?

Expert opinion on drug discovery·2026
Same journal

Balancing optimism versus potential risks of AI-driven drug discovery.

Expert opinion on drug discovery·2026
Same journal

Trustworthy and explainable AI for drug discovery.

Expert opinion on drug discovery·2026
See all related articles

Related Experiment Video

Updated: Mar 25, 2026

ExCYT: A Graphical User Interface for Streamlining Analysis of High-Dimensional Cytometry Data
05:12

ExCYT: A Graphical User Interface for Streamlining Analysis of High-Dimensional Cytometry Data

Published on: January 16, 2019

12.0K

Recent advances in quantitative high throughput and high content data analysis.

Ioannis K Moutsatsos1, Christian N Parker1

  • 1a Novartis Institute of Biomedical Research , Novartis - Developmental and Molecular Pathways (DMP) , Basel , Switzerland.

Expert Opinion on Drug Discovery
|March 1, 2016
PubMed
Summary
This summary is machine-generated.

Advancements in high throughput screening necessitate improved data analysis. This review covers new methods for analyzing complex screening data, promoting best practices and open-source tools for biological discovery.

Keywords:
Data analysisHigh Content ScreeningHigh Throughput ScreeningqHTS

More Related Videos

High Throughput, Absolute Determination of the Content of a Selected Protein at Tissue Levels Using Quantitative Dot Blot Analysis QDB
08:10

High Throughput, Absolute Determination of the Content of a Selected Protein at Tissue Levels Using Quantitative Dot Blot Analysis QDB

Published on: August 21, 2018

11.6K
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.9K

Related Experiment Videos

Last Updated: Mar 25, 2026

ExCYT: A Graphical User Interface for Streamlining Analysis of High-Dimensional Cytometry Data
05:12

ExCYT: A Graphical User Interface for Streamlining Analysis of High-Dimensional Cytometry Data

Published on: January 16, 2019

12.0K
High Throughput, Absolute Determination of the Content of a Selected Protein at Tissue Levels Using Quantitative Dot Blot Analysis QDB
08:10

High Throughput, Absolute Determination of the Content of a Selected Protein at Tissue Levels Using Quantitative Dot Blot Analysis QDB

Published on: August 21, 2018

11.6K
High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions
14:58

High-Throughput Transcriptome Analysis for Investigating Host-Pathogen Interactions

Published on: March 5, 2022

4.9K

Area of Science:

  • Genomics
  • High Throughput Screening
  • Bioinformatics

Background:

  • High throughput screening (HTS) is a fundamental technique for biological exploration.
  • Technological progress in HTS, including increased capacity and multiparametric readouts, demands enhanced data analysis strategies.

Purpose of the Study:

  • To review recent advances in analyzing high throughput screening data.
  • To discuss methods for handling complex, large-scale screening datasets, including arrayed and cell-by-cell data.
  • To highlight open-source tools and best practices for screening data analysis.

Main Methods:

  • Analysis of arrayed screening data.
  • Analysis of cell-by-cell data from image cytometry and flow cytometry.
  • Development of methods for prioritizing gene targets when using multiple genomic reagents.

Main Results:

  • Identification and review of recent advances in HTS data analysis techniques.
  • Discussion of open-source data analysis methods contributing to consensus best practices.
  • Exploration of challenges posed by screening multiple genomic reagents.

Conclusions:

  • Growing data complexity in HTS requires accessible data analysis tools and novel visualizations for quality control and interpretation.
  • Advanced statistical and machine learning algorithms are crucial for identifying patterns in massive datasets.
  • User-friendly, iterative tools are needed for laboratory scientists to improve complex analysis outcomes.